Gaertner FC - Search Results

1

Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.

Eiber M, Takei T, Souvatzoglou M, Mayerhoefer ME, Fürst S, Gaertner FC, Loeffelbein DJ, Rummeny EJ, Ziegler SI, Schwaiger M, Beer AJ. Eiber M, et al. Among authors: gaertner fc. J Nucl Med. 2014 Feb;55(2):191-7. doi: 10.2967/jnumed.113.123646. Epub 2013 Dec 5. J Nucl Med. 2014. PMID: 24309383 Free article.

2

Higher Validity, Lower Radiation: A New Ictal Single-Photon Emission Computed Tomography Framework.

Bitzer F, Walger L, Bauer T, Schulte F, Gaertner FC, Schmitz M, Schidlowski M, von Wrede R, Rácz A, Baumgartner T, Gnatkovsky V, Paech D, Borger V, Vatter H, Weber B, Michels DL, Stöcker T, Essler M, Sander JW, Radbruch A, Surges R, Rüber T. Bitzer F, et al. Among authors: gaertner fc. Ann Neurol. 2024 Dec;96(6):1160-1173. doi: 10.1002/ana.27061. Epub 2024 Aug 21. Ann Neurol. 2024. PMID: 39166769

3

[PET-CT for neuroendocrine tumors and nuclear medicine therapy options].

Scheidhauer K, Miederer M, Gaertner FC. Scheidhauer K, et al. Among authors: gaertner fc. Radiologe. 2009 Mar;49(3):217-23. doi: 10.1007/s00117-008-1784-9. Radiologe. 2009. PMID: 19296068 Review. German.

4

Molecular imaging of avb3 expression in cancer patients.

Gaertner FC, Schwaiger M, Beer AJ. Gaertner FC, et al. Q J Nucl Med Mol Imaging. 2010 Jun 18. Online ahead of print. Q J Nucl Med Mol Imaging. 2010. PMID: 20559198

5

Molecular imaging of αvß3 expression in cancer patients.

Gaertner FC, Schwaiger M, Beer AJ. Gaertner FC, et al. Q J Nucl Med Mol Imaging. 2010 Jun;54(3):309-26. Q J Nucl Med Mol Imaging. 2010. PMID: 20639816 Review.

6

Imaging of hypoxia using PET and MRI.

Gaertner FC, Souvatzoglou M, Brix G, Beer AJ. Gaertner FC, et al. Curr Pharm Biotechnol. 2012 Mar;13(4):552-70. doi: 10.2174/138920112799436267. Curr Pharm Biotechnol. 2012. PMID: 22214501 Review.

7

Radiolabelled RGD peptides for imaging and therapy.

Gaertner FC, Kessler H, Wester HJ, Schwaiger M, Beer AJ. Gaertner FC, et al. Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S126-38. doi: 10.1007/s00259-011-2028-1. Eur J Nucl Med Mol Imaging. 2012. PMID: 22388629 Review.

8

Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.

Gaertner FC, Beer AJ, Souvatzoglou M, Eiber M, Fürst S, Ziegler SI, Brohl F, Schwaiger M, Scheidhauer K. Gaertner FC, et al. Invest Radiol. 2013 May;48(5):263-72. doi: 10.1097/RLI.0b013e31828234d0. Invest Radiol. 2013. PMID: 23385399

9

PET/MR: a paradigm shift.

Gaertner FC, Fürst S, Schwaiger M. Gaertner FC, et al. Cancer Imaging. 2013 Feb 27;13(1):36-52. doi: 10.1102/1470-7330.2013.0005. Cancer Imaging. 2013. PMID: 23446110 Free PMC article. Review.

10

Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer.

Souvatzoglou M, Eiber M, Takei T, Fürst S, Maurer T, Gaertner F, Geinitz H, Drzezga A, Ziegler S, Nekolla SG, Rummeny EJ, Schwaiger M, Beer AJ. Souvatzoglou M, et al. Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1486-99. doi: 10.1007/s00259-013-2467-y. Epub 2013 Jul 2. Eur J Nucl Med Mol Imaging. 2013. PMID: 23817684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters